Adherence with statins and all‐cause mortality in days with high temperature
Pharmacoepidemiology and Drug Safety · 2024
DOI: 10.1002/pds.5817 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Gabriel Chodick und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Hot Temperature, Drug Monitoring. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
It has been suggested that statins may exert thermo‐protective effects that can reduce mortality on hot days. We aimed to examine the relationship between statin adherence and mortality in days with high temperature.
Methods
Utilizing data from a prior historical new‐user cohort study, we analyzed a cohort of 229 918 individuals within a state‐mandated health provider in Israel who initiated statin therapy between 1998 and 2006. Adherence to statins was assessed through the mean proportion of days covered (PDC) with statins during the follow‐up period. The study's primary outcome was all‐cause mortality during hot days.
Results
During the study follow‐up period, a total of 13 165 individuals (5.7%) died. In a multivariable model, a 10% increase in PDC with statins was associated with an HR of (0.85; 95% CI: 0.72–1.00) for deaths ( n = 16) in extremely hot days (≥39°C). This association was numerically stronger compared to HR = 0.94 (0.93–0.94) in cooler days and displayed a significant difference between sexes. In males, the fully‐adjusted HR for a 10% increase in PDC with statins was 0.66 (0.45–0.95), while in women, it was 0.98 (0.78–1.23). In contrast, no such effect modification was observed for death in cooler days.
Conclusions
These findings align with earlier research, supporting the notion that adherence with statin treatment may be associated with a reduced risk of death during extremely hot days, particularly among men.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
- MaccabiTech, Maccabi Institute for Research, Maccabi Healthcare Service, Tel Aviv, Israel.
- Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
- Department of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Gabriel Chodick
Zitieren
APA
Chodick, G., Rotem, R. S., Miano, T. A., Bilker, W. B., & Hennessy, S. (2024). Adherence with statins and all‐cause mortality in days with high temperature. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.5817
Vancouver
Chodick G, Rotem RS, Miano TA, Bilker WB, Hennessy S. Adherence with statins and all‐cause mortality in days with high temperature. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.5817
BibTeX
@article{Chodick2024,
author = {Chodick, Gabriel and Rotem, Ran S and Miano, Todd A and Bilker, Warren B and Hennessy, Sean},
title = {Adherence with statins and all‐cause mortality in days with high temperature},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
doi = {10.1002/pds.5817}
}
EUVIMED